Co-localization of hypoxia and apoptosis in irradiated and untreated HCT116 human colon carcinoma xenografts

Advances in Experimental Medicine and Biology

Volumn 454, Issue , 1998, Pages 611-618

  Koch, Cameron J ^a   Chasan, Jana E ^a   Timothy Jenkins, W ^a   Chan, Cecilia Y ^a   Laughlin, Kristine M ^a   Evans, Sydney M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NITROIMIDAZOLE; OXYGEN;

ANIMAL CELL; APOPTOSIS; CANCER GRAFT; COLON CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OXYGEN TISSUE LEVEL; OXYGEN TRANSPORT; PATHOPHYSIOLOGY; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RADIATION EXPOSURE; XENOGRAFT;

ANIMALIA; MUS MUSCULUS;

EID: 0032427774     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4863-8_72     Document Type: Conference Paper

References (23)

1. J. F. R. KERR, A. H. WYLLIE, and A. R. CURRIE, Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Brit. J. Cancer 26, 239-257 (1972).
2. A. H. WYLLIE, J. F. R. KERR, and A. R. CURRIE, Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306 (1980).
3. M. B. KASTAN, O. ONYEKWERE, D. SIDRANSKY, B. VOGELSTEIN, and R. W. CRAIG, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
4. W. S. EL-DEIRY, J. W. HARPER, P. M. O'CONNOR, V. E. VELCULESCU, C. E. CANMAN, J. JACKMAN, J. A. PIETENPOL, M. BURRELL, D. E. HILL, Y. WANG, K. G. WIMAN, W. E. MERCER, M. B. KASTAN, K. W. KOHN, S. J. ELLEDGE, K. W. KINZLER, and B. VOGELSTEIN, WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54, 1169-1174 (1994).
5. R. E. LANGLEY, S. T. PALAYOOR, C. N. COLEMAN, and E. A. BUMAP, Modifiers of radiation-induced apoptosis. Radiat. Res. 136, 320-326 (1993).
6. L. C. STEPHENS, N. R. HUNTER, K. K. ANG, L. MILAS, and R. E. MEYN, Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat. Res. 135, 75-80 (1993).
7. G. SHKLAR, and J. SCHWARTZ, A common pathway for the destruction of cancer cells: experimental evidence and clinical implications. Int. J. Oncol. 4, 215-224 (1994).
8. C. J. KOCH, S. M. EVANS, and E. M. LORD, Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoroproply)acetamide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Br. J. Cancer 72, 869-874 (1995).
9. S. M. EVANS, C. J. KOCH, B. JOINER, W. T. JENKINS, K. M. LAUGHLIN, and E. M. LORD, Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoroproply)acetamide]. Br. J. Cancer 72, 875-882 (1995).
10. S. M. EVANS, W. T. JENKINS, B. JOINER, E. M. LORD, and C. J. KOCH, 2-nitroimidazole (EF5) binding predicts radiation sensitivity in individual 9L subcutaneous tumors. Cancer Res. 56, 405-411 (1996).
11. D. M. BRIZEL, S. P. SCULLY, J. M. HARRELSON, L. J. LAYFIELD, J. M. BEAN, L. R. PROSNITZ, and M. W. DEWHIRST, Tissue oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941-943 (1996).
12. D. M. BRIZEL, G. S. SIBLEY, L. R. PROSNITZ, R. L. SCHER, and M. W. DEWHIRST, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38, 285-289 (1997).
13. M. HOCKEL, C. KNOOP, K. SCHLENGER, B. VORNDRAN, P. G. KNAPSTEIN, and P. VAUPEL, Intratumoral pO2 histography as predictive assay in advance cancer of the uterine cervix. Adv. Exptl. Med. Biol. 345, 445-450 (1994).
14. M. HOCKEL, K. SCHLENGER, B. ARAL, M. MITZE, U. SCHAFFER, and P. VAUPEL, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. CANCER RES. 56, 4509-4515 (1996).
15. R. J. MUSCHEL, E. BERNHARD, L. GARZA, W. G. MCKENNA, and C. KOCH, Induction of apoptosisat different oxygen tensions: evidence that oxygen radicals do not mediate apoptotic signalling. Cancer Res. 55, 995-998 (1995).
16. T. G. GRAEBER, C. OSMANIAN, T. JACKS, D. E. HOUSMAN, C. J. KOCH, S. W. LOWE, and A. J. GIACCIA, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91 (1996).
17. M. THIRY, Highly sensitive immunodetection of DNA on sections with exogenous terminal deoxynucleotidyl transferase and non-isotopic nucleotide analogs. J. Histochem. Cytochem. 40, 411-419 (1992).
18. E. M. LORD, L. W. HARWELL, and C. J. KOCH, Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res. 53, 5271-5276 (1993).
19. S. BIALIK, D. L. GEENEN, I. SASSON, R. CHENG, J. HORNER, S. M. EVANS, E. M. LORD, C. J. KOCH, and R. N. KITSIS, Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J. Clin. Investig. 100, 1363-1372 (1997).
20. K. M. LAUGHLIN, S. M. EVANS, W. T. JENKINS, M. TRACY, C. Y. CHAN, E. M. LORD, and C. J. KOCH, Biodistribution of the nitroimidazole EF5 [2-(2-nitro-iH-imidazole-1yl)-N-(2,2,3,3,3-pentafluoro propyl)-acelamide] in mice bearing subcutaneous EMT6 tumors. J. Pharmacol. Exptl. Therapeut. 277, 1049-1057 (1996).
21. A. J. FRANKO, C. J. KOCH, B. M. GARRECHT, J. SHARPLIN, and J. HOWORKO, Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res, 47, 5367-5376 (1987).
22. R. H. THOMLINSON, and L. H. GRAY, The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9, 539-579 (1955).
23. R. I. CLYMAN, C. Y. CHAN, F. MAURAY, Y. Q. CHEN, W. COX, S. R. SEIDNER, H. WEISS, E. M. LORD, N. WALEH, S. M. EVANS, and C. J. KOCH, Permanent anatomic closure of the newborn ductus erteriosus: the roles of postnatal constriction, hypoxia and gestation. New Eng. J. Med. Submitted, (1997).